within Pharmacolibrary.Drugs.N_NervousSystem.N02C_AntimigrainePreparations.N02CC08_Lasmiditan;

model Lasmiditan
  extends Pharmacolibrary.Drugs.ATC.N.N02CC08;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N02CC08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Lasmiditan is a selective serotonin 5-HT1F receptor agonist used for the acute treatment of migraine with or without aura in adults. It is approved for use in several countries, including the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data following single oral administration in healthy adult volunteers, both male and female.</p><h4>References</h4><ol><li><p>Tsai, M, et al., &amp; Wilbraham, D (2020). Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol. <i>Clinical pharmacology in drug development</i> 9(5) 629–638. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.768&quot;>10.1002/cpdd.768</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31950732/&quot;>https://pubmed.ncbi.nlm.nih.gov/31950732</a></p></li><li><p>Tsai, M, et al., &amp; Winner, P (2021). Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine. <i>Clinical pharmacokinetics</i> 60(6) 819–828. DOI:<a href=&quot;https://doi.org/10.1007/s40262-020-00966-z&quot;>10.1007/s40262-020-00966-z</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33565026/&quot;>https://pubmed.ncbi.nlm.nih.gov/33565026</a></p></li><li><p>Pergolizzi, JV, et al., &amp; Varrassi, G (2024). An update on pharmacotherapy for trigeminal neuralgia. <i>Expert review of neurotherapeutics</i> 24(8) 773–786. DOI:<a href=&quot;https://doi.org/10.1080/14737175.2024.2365946&quot;>10.1080/14737175.2024.2365946</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38870050/&quot;>https://pubmed.ncbi.nlm.nih.gov/38870050</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Lasmiditan;
